Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 144,178 | 189,718 | 189,818 | 177,347 | 146,632 |
| Marketable Securities | 443,615 | 583,658 | 678,125 | 769,734 | 841,774 |
| Receivables | 141,288 | 110,455 | 96,645 | 78,801 | 94,124 |
| Inventories | 15,281 | 15,856 | 15,613 | 16,441 | 16,234 |
| TOTAL | $774,009 | $954,368 | $1,011,140 | $1,066,233 | $1,122,365 |
| Non-Current Assets | |||||
| PPE Net | 59,088 | 52,585 | 46,354 | 42,910 | 37,123 |
| Intangibles | 846,006 | 807,182 | 805,601 | 799,420 | 794,915 |
| Other Non-Current Assets | 120,488 | 123,921 | 144,230 | 150,106 | 157,538 |
| TOTAL | $1,025,582 | $983,688 | $996,185 | $992,436 | $989,576 |
| Total Assets | $1,799,591 | $1,938,056 | $2,007,325 | $2,058,669 | $2,111,941 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 219,664 | 208,831 | 202,009 | 44,335 | 33,149 |
| Accounts payable and accrued liabilities | 246,521 | 288,784 | 252,329 | 235,921 | 205,636 |
| Other current liabilities | 1,450 | 1,460 | 1,222 | 1,250 | 1,250 |
| TOTAL | $476,776 | $509,348 | $465,261 | $290,962 | $250,949 |
| Non-Current Liabilities | |||||
| Long Term Debt | 956,979 | 956,588 | 952,153 | 1,095,325 | 1,091,873 |
| Deferred Revenues | N/A | N/A | 0 | N/A | 1,887 |
| Other Non-Current Liabilities | 300,632 | 313,519 | 328,199 | 319,017 | 319,755 |
| TOTAL | $1,413,396 | $1,427,270 | $1,437,138 | $1,571,130 | $1,568,416 |
| Total Liabilities | $1,890,172 | $1,936,618 | $1,902,399 | $1,862,092 | $1,819,365 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,338 | 71,362 | 70,698 | 70,605 | 70,456 |
| Common Shares | 71 | 71 | 70 | 70 | 70 |
| Retained earnings | -2,224,683 | -2,097,957 | -1,954,717 | -1,821,093 | -1,702,723 |
| Other shareholders' equity | -18,608 | -24,282 | -32,961 | -46,087 | -38,743 |
| TOTAL | $-90,581 | $1,438 | $104,926 | $196,577 | $292,576 |
| Total Liabilities And Equity | $1,799,591 | $1,938,056 | $2,007,325 | $2,058,669 | $2,111,941 |